0001225208-18-009351.txt : 20180515 0001225208-18-009351.hdr.sgml : 20180515 20180515173000 ACCESSION NUMBER: 0001225208-18-009351 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180511 FILED AS OF DATE: 20180515 DATE AS OF CHANGE: 20180515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER G LEONARD JR CENTRAL INDEX KEY: 0001201715 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 18837995 MAIL ADDRESS: STREET 1: 755 PAGE MILL ROAD, SUITE A-200 CITY: PALO ALTO STATE: CA ZIP: 94304-1005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml X0306 4 2018-05-11 0001088856 CORCEPT THERAPEUTICS INC CORT 0001201715 BAKER G LEONARD JR 755 PAGE MILL ROAD, SUITE A-200 PALO ALTO CA 94304-1005 1 Common Stock 2018-05-11 4 M 0 30000.0000 2.2300 A 806838.0000 D Common Stock 2018-05-11 4 S 0 30000.0000 16.0104 D 776838.0000 D Common Stock 2613634.0000 I By Ltd Partnership Common Stock 955055.0000 I By Trust Stock Option (Right To Buy) 2.2300 2018-05-11 4 M 0 30000.0000 0.0000 D 2008-07-10 2018-06-10 Common Stock 30000.0000 0.0000 D The reporting person shares pecuniary interest in these shares with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in these shares. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.22, inclusive. The reporting person undertakes to provide to Corcept Therapeutics Incorporated, and any security holder of Corcept Therapeutics Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust. /s/ Robert Yin, by power of attorney 2018-05-14